Background Severe aortic stenosis (AS) patients with left ventricular ejection fraction (LVEF) <20% are currently excluded from transcatheter aortic valve implant trials and are believed to be at higher risk…
Introduction Pivotal ranolazine trials did not include patients with refractory angina on optimal antianginal medications. The purpose of this study was to evaluate the efficacy and safety of ranolazine for…
Aim Our prospective in this study to test whether increase in the clopidogrel maintenance dose results in increased platelet inhibition that may be reflected in decreasing major adverse cardiac effects…
Background Late DES thrombosis has emerged as an important issue. At present, light transmission aggregometry (LTA) remains the gold standard for determining adequate platelet inhibition for DES patients on clopidogrel….
Background VEGF is a key regulator of angiogenesis. It is thought to be implicated in the pathogenesis of atherosclerotic plaque neovascularization and thus promotes its infiltration by inflammatory cells with…
Background and aim Fractional flow reserve (FFR) is routinely used for coronary lesion assessment. Maximal coronary vasodilatation can be accomplished by intracoronary (IC) and intravenous (IV) adenosine (the gold standard),…
Background Late stent thrombosis remains a major concern with drug-eluting stents (DES). Retrospective analysis of such cases has shown a clustering of such events post sudden stoppage. Prior studies have…
Background The association between early discontinuation of clopidogrel after drug-eluting stent (DES) implantation and an increase risk of adverse cardiovascular events is well documented. However, little is known about the…
Background Cardiogenic shock (CS) is one of the most important causes of death in patients hospitalized in coronary care units. The primary aim was to evaluate the predictive effect of…
Introduction and aim Coronary artery disease (CAD) in Saudis is reaching epidemic levels; type II diabetes (DM) is the highest in the region. The pattern and extent of coronary atherothrombosis…
